84 related articles for article (PubMed ID: 15842528)
1. Patients with Type 2 diabetes treated with metformin: prevalence of contraindications and their correlation with discontinuation.
Rakovac I; Jeitler K; Gfrerer RJ; Habacher W; Seereiner S; Mrak P; Pieber TR;
Diabet Med; 2005 May; 22(5):662-4. PubMed ID: 15842528
[No Abstract] [Full Text] [Related]
2. [Classic drug in diabetes therapy. Revise contraindications?].
Aumiller J
MMW Fortschr Med; 2007 May; 149(22):14. PubMed ID: 18074455
[No Abstract] [Full Text] [Related]
3. Metformin therapy in patients with type 2 diabetes complicated by heart failure.
Inzucchi SE; Masoudi FA; McGuire DK
Am Heart J; 2007 Dec; 154(6):e45. PubMed ID: 18035066
[No Abstract] [Full Text] [Related]
4. Metformin's contraindications should be contraindicated.
McCormack J; Johns K; Tildesley H
CMAJ; 2005 Aug; 173(5):502-4. PubMed ID: 16129871
[No Abstract] [Full Text] [Related]
5. Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.
Almirall J; Bricullé M; Gonzalez-Clemente JM
Nephrol Dial Transplant; 2008 Jul; 23(7):2436-8. PubMed ID: 18388117
[No Abstract] [Full Text] [Related]
6. Metformin in type 2 diabetes.
Fox GN
J Fam Pract; 2004 Nov; 53(11):900. PubMed ID: 15527727
[No Abstract] [Full Text] [Related]
7. [Metformin. Contraindications in heart failure reconsidered].
Schmitt-Hönl B
Med Monatsschr Pharm; 2008 Apr; 31(4):148-9. PubMed ID: 18497248
[No Abstract] [Full Text] [Related]
8. Using metformin in the presence of renal disease.
Chowdhury TA; Wright R; Yaqoob MM
BMJ; 2015 Apr; 350():h1758. PubMed ID: 25873532
[No Abstract] [Full Text] [Related]
9. Contraindications to use of metformin. Metformin may be useful in gestational diabetes.
Hague WM; Davoren PM; Oliver J; Rowan J
BMJ; 2003 Apr; 326(7392):762; author reply 762. PubMed ID: 12680386
[No Abstract] [Full Text] [Related]
10. [Guideline: type 2 diabetes mellitus therapy: metformin, a critical perspective].
Pinto D; Heleno B; Gallego R; Santos I; Santiago LM; Maria V
Acta Med Port; 2011; 24(2):331-8. PubMed ID: 22011607
[TBL] [Abstract][Full Text] [Related]
11. Metformin--current restrictions should be alleviated.
Stades AM; Heikens JT; Holleman F; Hoekstra JB
J Intern Med; 2004 Oct; 256(4):358; discussion 359. PubMed ID: 15367179
[No Abstract] [Full Text] [Related]
12. Fulminant lactic acidosis in two patients with Type 2 diabetes treated with metformin.
Brassøe R; Elkmann T; Hempel M; Gravholt CH
Diabet Med; 2005 Oct; 22(10):1451-3. PubMed ID: 16176212
[TBL] [Abstract][Full Text] [Related]
13. [Metformin should not be used by patients with reduced renal function].
Gudmundsdottir H; Brørs O; Os I
Tidsskr Nor Laegeforen; 2008 Apr; 128(8):936-7. PubMed ID: 18431417
[No Abstract] [Full Text] [Related]
14. Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq.
Mansour AA; Habib OS
Saudi Med J; 2007 Dec; 28(12):1919-21. PubMed ID: 18060234
[No Abstract] [Full Text] [Related]
15. Contraindications to use of metformin. Age and creatinine clearance need to be taken into consideration.
Elder AT
BMJ; 2003 Apr; 326(7392):762; author reply 762. PubMed ID: 12676851
[No Abstract] [Full Text] [Related]
16. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
Kirby M
Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
[No Abstract] [Full Text] [Related]
17. To: Holstein A, Stumvoll M (2005) Contraindications can damage your health--is metformin a case in point? Diabetologia 48:2454-2459.
Ma RC; Chow CC; Tong PC; Chan JC; Cockram CS
Diabetologia; 2006 May; 49(5):1127-8. PubMed ID: 16565848
[No Abstract] [Full Text] [Related]
18. Contraindications to metformin therapy among patients with type 2 diabetes mellitus.
Sweileh WM
Pharm World Sci; 2007 Dec; 29(6):587-92. PubMed ID: 17333496
[TBL] [Abstract][Full Text] [Related]
19. The FDA Revises Restrictions on Metformin Use in Kidney Impairment.
Aschenbrenner DS
Am J Nurs; 2016 Aug; 116(8):22-3. PubMed ID: 27466921
[No Abstract] [Full Text] [Related]
20. Levels of evidence needed for changing indications, contraindications, and Food and Drug Administration labeling: the case of metformin.
Eurich DT; Majumdar SR; McAlister FA; Tsuyuki RT; Johnson JA
Arch Intern Med; 2011 Jun; 171(11):1042-3; author reply 1043. PubMed ID: 21670379
[No Abstract] [Full Text] [Related]
[Next] [New Search]
